Implications and Opportunities of Applying QbD Principles to Analytical Measurement
The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods.
Commercialising cellular therapies faster
February 1st 2010There is much scientific evidence of the early successes of whole cell therapies as disease cures in chronic conditions and disease-modifiers in acute conditions, but limited cases of successfully transferring these discoveries to commercial products or therapies.
Cushioning pharma's fall from the patent precipice
February 1st 2010Pharma faces imminent expiries of key patents and increasing competition from generics. To protect what they already have, or what they will invent or acquire, companies must give patent protection the attention it deserves.
Boosting efficiency and safety by minimising aggregation
February 1st 2010Last year, the UK's National Institute for Health and Clinical Excellence (NICE) decided that a new biopharmaceutical cancer drug costing £3000 per month, which could extend a patient's life by 6 months, was not value for money and would not be prescribed in the UK.